Chemomab Therapeutics Ltd. (CMMB) income statement
CMMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 5/30
$1.14−0.41 (-26.45%)
Close on Nov 19, 2026Market cap $8.20MP/E 0.8Yield –
Chemomab Therapeutics Ltd. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -69.5%
Financial strength
- Current ratio
- 6.41
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 386.3%
Valuation
- P/E ratio
- 0.8
- Price to sales
- –
- Price to book
- 0.94
- Dividend yield
- –
See a number that looks wrong?